SCHEMBL38655243

SCHEMBL38655243

CC(CN1C(=O)c2ccccc2C1=O)OCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.55
HPGD P15428 3/20 0.55
NPC1 O15118 3/20 0.55
TSHR P16473 2/20 0.55
NPSR1 Q6W5P4 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.51
MAPK1 P28482 1/20 0.50
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 1/20 0.47
GLS O94925 1/20 0.46
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
GAA P10253 1/20 0.45
MAOB P27338 2/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24530130 0.87 HPGD (0.53) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL29642608 0.86 HPGD (0.51) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL10062194 0.85 HPGD (0.57) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL12459480 0.85 L3MBTL1 (0.58) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL12632010 0.83 KMT2A (0.46) RAB9AHPGDNPC1TSHRMAPK1
SCHEMBL8385954 0.82 RAB9A (0.56) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL9794722 0.82 HPGD (0.54) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL20143804 0.80 RAB9A (0.48) RAB9AHPGDNPC1TSHRNPSR1
SCHEMBL14960666 0.80 KMT2A (0.50) RAB9AHPGDNPC1TSHRMAPK1
SCHEMBL22413268 0.78 RAB9A (0.55) RAB9AHPGDNPC1TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104409-A1 MULTIMERIC MANGANESE CONTRAST AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2026-05-21 WO disclosed
EP-4741400-A1 MULTIMERIC MANGANESE CONTRAST AGENTS Bayer Aktiengesellschaft (DE) 2026-05-13 EP disclosed